MedPath

Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring.

Completed
Conditions
Patient Education as Topic
Surveys and Questionnaires
Medication Adherence
Pulmonary Disease, Chronic Obstructive
Diabetes Mellitus, Type 2
Heart Failure
Registration Number
NCT02865525
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Medication non-adherence is an economic problem and a major public health challenge. Factors influencing medication adherence can be modelled according to five dimensions: disease, medication, patient and its close relatives, demographic and socioeconomic factors and health care system. A tool is needed to qualify medication adherence in order to adapt tailored support for individual patients to promote and optimize adherence to therapy.

The objective of this work is to present the preliminary results of QUILAM project which is divided into 3 phases: 1. Development of a tool to assess barriers to medication adherence in chronic patient (COPD, Heart failure, Type 2 diabetes) ; 2. Validation of the instrument (especially against clinical criteria) ; 3. Evaluation of the sensitivity of the tool during educational interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
282
Inclusion Criteria
  • Patient with at least one of the following pathologies: diabetes type II, COPD, heart failure
  • person available for a follow-up of 1 year
  • Affiliated to the social security or recipient of such a regime
Exclusion Criteria
  • Persons referred to in articles L1121-5 and L1121-8 in the french public health code
  • Patient who do not speak french

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of events 'hospitalization and death' for 2 patient groups defined through the questionnaire QUILAM score12 month
Secondary Outcome Measures
NameTimeMethod
Reliability over time of the questionnaire (test-retest J0 - J15)12 month
Number of clinical events for 2 patient groups12 month
Feasibility and acceptability of the questionnaire (duration / missing data)12 month
External construct validity (Girerd, SatMedQ, BMQ)12 month
Number of events 'hospitalization and death' for 2 patient groups separate with different cut off12 month

Trial Locations

Locations (1)

Grenoble University Hospital

🇫🇷

Grenoble cedex 9, France

Grenoble University Hospital
🇫🇷Grenoble cedex 9, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.